XRTX — XORTX Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Xortx Therapeutics Inc Says Independent Proxy Firm, ISS, Recommends Shareholders Vote For Share Consolidation Resolution
Brief: XORTX Appoints Chief Financial Officer
Brief: Xortx Announces 180-Day Extension To Regain Compliance With Nasdaq Minimum Bid Price Deficiency
Brief: FDA Confirms Eligibility Of XORLO For Accelerated Approval
Brief: Xortx Announces Receipt Of FDA Orphan Drug Tag To Treat Kidney Disease
Brief: Xortx Therapeutics Inc- Announce Submission Of A Type D Meeting Request To Us FDA And A Response Setting Date For A Virtual Meeting On May 1, 2023
XORTX Therapeutics rises on 'orphan drug' request for kidney disease therapy
Brief: XORTX Announces Submission Of Orphan Drug Designation Request For XRx-008 Program
Brief: XORTX Therapeutics Files For Mixed Shelf Of Up To $50 Mln
XORTX Therapeutics jumps on positive results for kidney disease drug
XORTX Therapeutics jumps on positive results for kidney disease drug
Brief: Xortx Announces Positive Topline Results From Xrx-Oxy-101 Clinical Trial
U.S. STOCKS ON THE MOVE-Vroom, Microsoft, Amgen
Brief: XORTX Files Provisional Patent To Diagnose And Treat Individuals At Risk Of Polycystic Kidney Disease Progression
Brief: XORTX Announces New Proof Of Concept Data In Autosomal Dominant Polycystic Kidney Disease
Brief: Xortx Completes Screening $ Enrollment In Bridging Pharmacokinetics Study
Brief: XORTX Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Brief: Xortx Receives Further No Objection Letter From Health Canada
Brief: Xortx Completes Positive Pre-Phase 3 Meeting With U.S. FDA